160 related articles for article (PubMed ID: 22308076)
1. Effect of grapefruit juice and ritonavir on pharmacokinetics of lopinavir in Wistar rats.
Ravi PR; Vats R; Thakur R; Srivani S; Aditya N
Phytother Res; 2012 Oct; 26(10):1490-5. PubMed ID: 22308076
[TBL] [Abstract][Full Text] [Related]
2. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
Panchagnula R; Bansal T; Varma MV; Kaul CL
Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
[TBL] [Abstract][Full Text] [Related]
3. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation.
Ravi PR; Vats R; Dalal V; Murthy AN
J Pharm Pharmacol; 2014 Jul; 66(7):912-26. PubMed ID: 24697749
[TBL] [Abstract][Full Text] [Related]
4. Esterase inhibition attribute of grapefruit juice leading to a new drug interaction.
Li P; Callery PS; Gan LS; Balani SK
Drug Metab Dispos; 2007 Jul; 35(7):1023-31. PubMed ID: 17392396
[TBL] [Abstract][Full Text] [Related]
5. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat.
Shirasaka Y; Kuraoka E; Spahn-Langguth H; Nakanishi T; Langguth P; Tamai I
J Pharmacol Exp Ther; 2010 Jan; 332(1):181-9. PubMed ID: 19779132
[TBL] [Abstract][Full Text] [Related]
6. The plasma and intracellular steady-state pharmacokinetics of lopinavir/ritonavir in HIV-1-infected patients.
Crommentuyn KM; Mulder JW; Mairuhu AT; van Gorp EC; Meenhorst PL; Huitema AD; Beijnen JH
Antivir Ther; 2004 Oct; 9(5):779-85. PubMed ID: 15535416
[TBL] [Abstract][Full Text] [Related]
7. Influence of grapefruit juice on the pharmacokinetics of diltiazem in Wistar rats upon single and multiple dosage regimens.
Boddu SP; Yamsani MR; Potharaju S; Veeraraghavan S; Rajak S; Kuma SV; Avery BA; Repka MA; Varanasi VS
Pharmazie; 2009 Aug; 64(8):525-31. PubMed ID: 19746842
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of inhibitors of cytochrome P450 3A (CYP3A) for pharmacokinetic enhancement of drugs.
Flentge CA; Randolph JT; Huang PP; Klein LL; Marsh KC; Harlan JE; Kempf DJ
Bioorg Med Chem Lett; 2009 Sep; 19(18):5444-8. PubMed ID: 19679477
[TBL] [Abstract][Full Text] [Related]
9. Effect of ciprofloxacin and grapefruit juice on oral pharmacokinetics of riluzole in Wistar rats.
Ravi PR; Vats R; Kora UR
J Pharm Pharmacol; 2013 Mar; 65(3):337-44. PubMed ID: 23356842
[TBL] [Abstract][Full Text] [Related]
10. Low dose lopinavir/ritonavir tablet achieves adequate pharmacokinetic parameters in HIV-infected Thai adolescents.
Klinklom A; Puthanakit T; Gorowara M; Phasomsap C; Kerr S; Sriheara C; Ananworanich J; Burger D; Ruxrungtham K; Pancharoen C
Antivir Ther; 2012; 17(2):283-9. PubMed ID: 22293065
[TBL] [Abstract][Full Text] [Related]
11. Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: comparison with ritonavir.
Culm-Merdek KE; von Moltke LL; Gan L; Horan KA; Reynolds R; Harmatz JS; Court MH; Greenblatt DJ
Clin Pharmacol Ther; 2006 Mar; 79(3):243-54. PubMed ID: 16513448
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of lopinavir/ritonavir (Kaletra) in HIV-infected patients.
López Aspiroz E; Santos Buelga D; Cabrera Figueroa S; López Galera RM; Ribera Pascuet E; Domínguez-Gil Hurlé A; García Sánchez MJ
Ther Drug Monit; 2011 Oct; 33(5):573-82. PubMed ID: 21912331
[TBL] [Abstract][Full Text] [Related]
13. The effects of ritonavir and lopinavir/ritonavir on the pharmacokinetics of a novel CCR5 antagonist, aplaviroc, in healthy subjects.
Adkison KK; Shachoy-Clark A; Fang L; Lou Y; Otto VR; Berrey MM; Piscitelli SC
Br J Clin Pharmacol; 2006 Sep; 62(3):336-44. PubMed ID: 16934050
[TBL] [Abstract][Full Text] [Related]
14. Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance.
Molina JM; Ait-Khaled M; Rinaldi R; Penco G; Baril JG; Cauda R; Soriano V; Pialoux G; Wire MB; Lou Y; Givens N; Craig C; Nichols WG; Barbosa I; Yeo J;
J Antimicrob Chemother; 2009 Aug; 64(2):398-410. PubMed ID: 19515730
[TBL] [Abstract][Full Text] [Related]
15. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction.
Li P; Callery PS; Gan LS; Balani SK
Drug Metab Dispos; 2007 Jul; 35(7):1203-8. PubMed ID: 17452418
[TBL] [Abstract][Full Text] [Related]
16. Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen.
Ribera E; Azuaje C; Lopez RM; Diaz M; Feijoo M; Pou L; Crespo M; Curran A; Ocaña I; Pahissa A
AIDS; 2006 May; 20(8):1131-9. PubMed ID: 16691064
[TBL] [Abstract][Full Text] [Related]
17. Development and in vivo evaluation of child-friendly lopinavir/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles.
Pham K; Li D; Guo S; Penzak S; Dong X
J Control Release; 2016 Mar; 226():88-97. PubMed ID: 26849919
[TBL] [Abstract][Full Text] [Related]
18. Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients.
Wyen C; Fuhr U; Frank D; Aarnoutse RE; Klaassen T; Lazar A; Seeringer A; Doroshyenko O; Kirchheiner JC; Abdulrazik F; Schmeisser N; Lehmann C; Hein W; Schömig E; Burger DM; Fätkenheuer G; Jetter A
Clin Pharmacol Ther; 2008 Jul; 84(1):75-82. PubMed ID: 18183034
[TBL] [Abstract][Full Text] [Related]
19. Influence of Panax ginseng on the steady state pharmacokinetic profile of lopinavir-ritonavir in healthy volunteers.
Calderón MM; Chairez CL; Gordon LA; Alfaro RM; Kovacs JA; Penzak SR
Pharmacotherapy; 2014 Nov; 34(11):1151-8. PubMed ID: 25142999
[TBL] [Abstract][Full Text] [Related]
20. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.
Dahan A; Amidon GL
Pharm Res; 2009 Apr; 26(4):883-92. PubMed ID: 19048359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
